Finanzen von Bioceres Crop Solutions Corp (BIOX)BIOXBioceres Crop Solutions Corp

Bioceres Crop Solutions Corp (BIOX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Other, accounting for 100.0% of total sales, equivalent to $39.40M. Other significant revenue streams include Crop protection and Crop nutrituion. Understanding this composition is critical for investors evaluating how BIOX navigates market cycles within the Agricultural Chemicals industry.

Evaluating the bottom line, Bioceres Crop Solutions Corp maintains a gross margin of 24.21%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -6.32%, while the net margin is -55.79%. These profitability ratios, combined with a Return on Equity (ROE) of -33.43%, provide a clear picture of how effectively BIOX converts its operational activities into shareholder value.

In the context of the broader market, BIOX competes directly with industry leaders such as FNUC and SNES. With a market capitalization of $14.97M, it holds a significant position in the sector. When comparing efficiency, BIOX's gross margin of 24.21% stands against FNUC's N/A and SNES's 73.64%. Such benchmarking helps identify whether Bioceres Crop Solutions Corp is trading at a premium or discount relative to its financial performance.

The company reported a significant decline in total revenue, with a 23% year-over-year drop and a gross profit decrease of 30%. The net income has been negative for several quarters, with the latest reported net income of -$27,500,000 in Q4 2026.